The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional) |
93.853 |
PAR-21-056 |
| NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required) |
93.867 |
PAR-21-042 |
| Outstanding New Environmental Scientist (ONES) Award (R01 Clinical Trial Optional) |
93.113 |
RFA-ES-21-001 |
| NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional) |
93.233, 93.837, 93.838, 93.839, 93.840 |
PAR-21-079 |
| Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed) |
93.398 |
PAR-21-067 |
| NEI Collaborative Clinical Vision Research : Chair's Grant (UG1-Clinical Trial Required) |
93.867 |
PAR-21-041 |
| Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) |
93.242, 93.313 |
RFA-MH-21-105 |
| Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) |
93.398 |
PAR-21-066 |
| NEI Collaborative Clinical Vision Project: Resource Center Grant (UG1- Clinical Trial Required) |
93.867 |
PAR-21-043 |
| Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed) |
93.398 |
PAR-21-065 |
| Social Drivers of Mental Illnesses in Low- and Middle-Income Countries: Mechanisms and Pathways of Interventions for Youth (R01 Clinical Trial Optional) |
93.242 |
RFA-MH-21-160 |
| Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01 Clinical trial not allowed) |
93.113, 93.273, 93.307, 93.399, 93.866 |
PAR-21-080 |
| Exploratory Centers for Interdisciplinary Research in Benign Urology (P20 Clinical Trial Optional) |
93.847 |
RFA-DK-20-033 |
| Strengthening HIV Prevention Efforts for Women in the Southern U.S. (R01 Clinical Trial Optional) |
93.242, 93.279, 93.307, 93.313 |
RFA-MH-21-151 |
| Addressing Health Disparities among Immigrant Populations through Effective Interventions (R01 Clinical Trial Optional) |
93.113, 93.273, 93.307, 93.393, 93.399 |
PAR-21-081 |
| Strengthening HIV Prevention Efforts for Women in the Southern U.S. (R34 Clinical Trial Optional) |
93.242, 93.279, 93.313 |
RFA-MH-21-150 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed) |
93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.350, 93.351, 93.361, 93.398, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.859, 93.865, 93.866, 93.867, 93.879, 93.989 |
PA-21-071 |
| Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional) |
93.273, 93.279, 93.399 |
PAR-21-022 |
| Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional) |
93.273, 93.279 |
PAR-21-023 |
| Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R01 Clinical Trial Optional) |
93.242 |
RFA-MH-21-110 |
| Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R34 Clinical Trial Optional) |
93.242 |
RFA-MH-21-111 |
| Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) |
93.846 |
PAR-21-053 |
| NIAAA Resource-Related Research Projects (R24 Clinical Trial Not Allowed) |
93.273 |
PAR-21-072 |
| Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R43/R44 Clinical Trial Optional) |
93.242 |
RFA-MH-21-112 |
| Understanding the Cellular and Molecular Mechanisms of Gastroparesis in Adults and Children (R01 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-20-030 |
| Detection of HIV for Self-Testing (R61/R33 Clinical Trial Not Allowed) |
93.242, 93.279, 93.855, 93.865 |
PAR-21-070 |
| Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required) |
93.846 |
PAR-21-045 |
| National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) |
93.393, 93.394, 93.395, 93.399 |
PAR-21-033 |
| NIAMS Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) |
93.846 |
PAR-21-036 |
| Exploring the Scientific Value of Existing or New Sepsis Human Biospecimen Collections (R21/R33 - Clinical Trial Not Allowed) |
93.859 |
PAR-21-077 |
| Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) |
93.393, 93.399 |
PAR-21-035 |
| Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) |
93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.313, 93.351, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.865, 93.866, 93.867, 93.879 |
PAR-21-038 |
| Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Humans Required) |
93.113, 93.121, 93.173, 93.213, 93.242, 93.273, 93.279, 93.307, 93.313, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.846, 93.853, 93.865, 93.866, 93.867, 93.879 |
PAR-21-039 |
| Promoting Viral Suppression among Individuals from Health Disparity Populations Engaged in HIV Care (R01 Clinical Trial Required) |
93.307 |
RFA-MD-21-002 |
| Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-21-007 |
| Limited Competition: Lasker Clinical Research Scholars Transition Award (R00 Clinical Trial Optional) |
93.233, 93.273, 93.398, 93.837, 93.838, 93.839, 93.840, 93.847, 93.855 |
PAR-20-315 |
| Multi-Level HIV Prevention Interventions for Individuals at the Highest Risk of HIV Infection (R01 Clinical Trial Optional) |
93.242, 93.307 |
RFA-MD-21-001 |
| Regional Technology Transfer Accelerator Hubs for IDeA States (STTR) (UT2 - Clinical Trial Not Allowed) |
93.859 |
RFA-GM-21-001 |
| NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Required) |
93.398 |
RFA-CA-20-057 |
| Treatments for Lewy Body Dementias--Exploratory Clinical Trial (U01 Clinical Trial Required) |
93.853, 93.866 |
RFA-NS-21-008 |
Search Results 2481-2520 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |
